121 related articles for article (PubMed ID: 358777)
21. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
[No Abstract] [Full Text] [Related]
22. Site-specific blockade of dopamine receptors by neuroleptic agents in human brain.
Borison RL; Fields JZ; Diamond BI
Neuropharmacology; 1981 Dec; 20(12B):1321-2. PubMed ID: 6119643
[No Abstract] [Full Text] [Related]
23. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
Lau YS; Runice C; Dowd F
J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
[TBL] [Abstract][Full Text] [Related]
24. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
Sibley DR; Creese I
Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
[TBL] [Abstract][Full Text] [Related]
25. Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
Ryan-Jastrow T; Gnegy ME
J Pharmacol Exp Ther; 1989 Feb; 248(2):626-31. PubMed ID: 2521900
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective blockade of cerebral dopamine receptors by sulpiride and sultopride [proceedings].
Clow A; Jenner P; Marsden CD; Reavill C; Theodorou A
Br J Pharmacol; 1979 Nov; 67(3):433P. PubMed ID: 497556
[No Abstract] [Full Text] [Related]
27. The affinities of ergot compounds for dopamine agonist and dopamine antagonist receptor sites.
Goldstein M; Lew JY; Sauter A; Lieberman A
Adv Biochem Psychopharmacol; 1980; 23():75-82. PubMed ID: 7395625
[No Abstract] [Full Text] [Related]
28. [Biochemistry and pharmacology of benzamides].
Boyer P
Sem Hop; 1983 Mar; 59(12):832-5. PubMed ID: 6306780
[TBL] [Abstract][Full Text] [Related]
29. [Difference in mechanism of action of sulpiride and haloperidol on dopamine brain turnover].
Imazu Y; Kobayashi K; Shomori T
Seishin Shinkeigaku Zasshi; 1988; 90(10):845-52. PubMed ID: 3251268
[No Abstract] [Full Text] [Related]
30. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
31. Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. I. Development and distribution of serotonin and dopamine-sensitive adenylate cyclases in rat and guinea pig brain.
Enjalbert A; Bourgoin S; Hamon M; Adrien J; Bockaert J
Mol Pharmacol; 1978 Jan; 14(1):2-10. PubMed ID: 625285
[No Abstract] [Full Text] [Related]
32. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of rat retinal dopamine receptors.
Qu ZX; Fertel R; Neff NH; Hadjiconstantinou M
J Pharmacol Exp Ther; 1989 Feb; 248(2):621-5. PubMed ID: 2493095
[TBL] [Abstract][Full Text] [Related]
34. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
Clement-Cormier Y
Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
[No Abstract] [Full Text] [Related]
35. Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings].
Delitala G; Stubbs WA; Yeo T; Jones A; Thorner MO; Besser GM
J Endocrinol; 1979 May; 81(2):121P. PubMed ID: 458305
[No Abstract] [Full Text] [Related]
36. Structure-activity relationships of dopamine agonists.
Cannon JG
Annu Rev Pharmacol Toxicol; 1983; 23():103-29. PubMed ID: 6347047
[No Abstract] [Full Text] [Related]
37. Effects of some ergot alkaloids on dopamine receptors of molluscan smooth muscle.
Ishii Y; Takayanagi I
J Pharmacobiodyn; 1982 Sep; 5(9):748-50. PubMed ID: 7153848
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the vascular dopamine receptor with other dopamine receptors.
Goldberg LI; Volkman PH; Kohli JD
Annu Rev Pharmacol Toxicol; 1978; 18():57-79. PubMed ID: 348069
[No Abstract] [Full Text] [Related]
39. Evaluation of the central effects of ergot alkaloids by means of electroencephalography.
Longo VG; Loizzo A
Pharmacology; 1978; 16 Suppl 1():189-92. PubMed ID: 643900
[TBL] [Abstract][Full Text] [Related]
40. LSD labels a novel dopamine receptor in molluscan nervous system.
Drummond AH; Bucher F; Levitan IB
Nature; 1978 Mar; 272(5651):368-70. PubMed ID: 24805
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
